Sanofi’s €300 Million Strategic Equity Investment in Innovent Biologics

Herbert Smith Freehills has advised Sanofi on the deal.The innnovative global healthcare company Sanofi announced its €300 million strategic equity investment in Chinese biopharmaceutical company Innovent…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here